Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

787 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma.
Pond GR, Agarwal N, Bellmunt J, Choueiri TK, Qu A, Fougeray R, Vaughn D, James ND, Salhi Y, Albers P, Niegisch G, Galsky MD, Wong YN, Ko YJ, Stadler WM, O'Donnell PH, Sridhar SS, Vogelzang NJ, Necchi A, Di Lorenzo G, Sternberg CN, Mehta A, Sonpavde G. Pond GR, et al. Among authors: choueiri tk. BJU Int. 2014 May;113(5b):E137-43. doi: 10.1111/bju.12564. BJU Int. 2014. PMID: 24219029
Sunitinib in renal-cell carcinoma: expanded indications.
Choueiri TK, Bellmunt J. Choueiri TK, et al. Lancet Oncol. 2009 Aug;10(8):740. doi: 10.1016/S1470-2045(09)70185-8. Epub 2009 Jul 15. Lancet Oncol. 2009. PMID: 19615941 Review. No abstract available.
Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens.
Bellmunt J, Choueiri TK, Fougeray R, Schutz FA, Salhi Y, Winquist E, Culine S, von der Maase H, Vaughn DJ, Rosenberg JE. Bellmunt J, et al. Among authors: choueiri tk. J Clin Oncol. 2010 Apr 10;28(11):1850-5. doi: 10.1200/JCO.2009.25.4599. Epub 2010 Mar 15. J Clin Oncol. 2010. PMID: 20231682 Clinical Trial.
Pazopanib: Clinical development of a potent anti-angiogenic drug.
Schutz FA, Choueiri TK, Sternberg CN. Schutz FA, et al. Among authors: choueiri tk. Crit Rev Oncol Hematol. 2011 Mar;77(3):163-71. doi: 10.1016/j.critrevonc.2010.02.012. Epub 2010 Apr 24. Crit Rev Oncol Hematol. 2011. PMID: 20456972 Review.
Recent advances in immunotherapy for the treatment of prostate cancer.
Sonpavde G, Agarwal N, Choueiri TK, Kantoff PW. Sonpavde G, et al. Among authors: choueiri tk. Expert Opin Biol Ther. 2011 Aug;11(8):997-1009. doi: 10.1517/14712598.2011.575357. Epub 2011 Jun 15. Expert Opin Biol Ther. 2011. PMID: 21675925 Review.
787 results